Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Brisbane, California
- Most recent report
- 8-K, filed Sep 15, 2026
- Incorporated
- Delaware
- Filings on record
- 474 filings
- On EDGAR
- CIK 1831828
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 22
News 8 of 63
Prospectuses and Registrations 8 of 26
- S-8 Registration statement for an employee plan Feb 27, 2026
- 424B5 Prospectus supplement for an offering Dec 10, 2025
- 424B5 Prospectus supplement for an offering Dec 8, 2025
- 424B5 Prospectus supplement for an offering Aug 5, 2025
- S-8 Registration statement for an employee plan Feb 28, 2025
- 424B5 Prospectus supplement for an offering Oct 30, 2024
- 424B5 Prospectus supplement for an offering Oct 29, 2024
- S-3ASR Automatic shelf registration Oct 28, 2024
Proxies 8 of 11
- DEFA14A Extra proxy material Apr 9, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 9, 2026
- DEFA14A Extra proxy material Apr 3, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 3, 2025
- DEFA14A Extra proxy material May 3, 2024
- DEFA14A Extra proxy material Apr 3, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 3, 2024
- DEFA14A Extra proxy material Mar 30, 2023
Ownership 8 of 322
- 4 Insider reported a trade Sep 17, 2026
- 4 Insider reported a trade Sep 14, 2026
- 4 Insider reported a trade Sep 4, 2026
- 144 Notice of a proposed sale of restricted stock Sep 2, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4/A Insider reported a trade, amended Aug 12, 2026
- 4/A Insider reported a trade, amended Aug 12, 2026
- 4/A Insider reported a trade, amended Aug 12, 2026
Other 8 of 30
- ARS Annual report sent to shareholders Apr 9, 2026
- ARS Annual report sent to shareholders Apr 3, 2025
- ARS Annual report sent to shareholders Apr 4, 2024
- S-3MEF Jan 29, 2024
- ARS Annual report sent to shareholders Mar 30, 2023
- EFFECT Notice that a registration became effective Jun 13, 2022
- UPLOAD Comment letter from SEC staff Jun 9, 2022
- CORRESP Reply to SEC staff Jun 9, 2022
Everything here comes from Vera Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.